U01.11.016 Vascular smooth muscle contraction and relaxation

Written by

in

Learning Objectives

  • Differentiate between the pathways for vascular smooth muscle contraction and relaxation.
  • Identify the role of the Ca^{2+}-calmodulin complex in activating Myosin Light Chain Kinase (MLCK).
  • Explain the mechanism of Nitric Oxide (NO) and cGMP in promoting vasodilation.
  • Master the “dephosphorylation” step managed by Myosin Light Chain Phosphatase (MLCP).

1. Mechanism of Contraction

Unlike skeletal muscle, smooth muscle does not use troponin. Instead, contraction is regulated by the phosphorylation of the myosin light chain.

  • Calcium Entry: Membrane depolarization opens L-type voltage-gated Ca^{2+} channels, increasing intracellular calcium.
  • The Complex: Ca^{2+} binds to Calmodulin, forming the Ca^{2+}-calmodulin complex.
  • Kinase Activation: This complex activates Myosin Light Chain Kinase (MLCK).
  • Phosphorylation: MLCK phosphorylates the myosin light chain, allowing myosin to bind with actin $\rightarrow$ Contraction.

2. Mechanism of Relaxation (Vasodilation)

Relaxation occurs when myosin is dephosphorylated, often triggered by endothelial signals like Nitric Oxide.

  • NO Production: Agonists (like ACh or Bradykinin) stimulate NO Synthase in endothelial cells to convert L-arginine into Nitric Oxide (NO).
  • Diffusion: NO diffuses from the endothelium into the smooth muscle cell.
  • cGMP Pathway: NO activates Guanylyl Cyclase, converting GTP to cGMP.
  • Phosphatase Activation: cGMP promotes the activity of Myosin Light Chain Phosphatase (MLCP).
  • Dephosphorylation: MLCP removes the phosphate from myosin, preventing actin-binding $\rightarrow$ Relaxation.

Clinical Notes & Step 1 Pearls:

  • Nitrates: Drugs like nitroglycerin provide an exogenous source of NO, leading to cGMP-mediated venodilation and reduced preload.
  • PDE-5 Inhibitors: Sildenafil (Viagra) inhibits the breakdown of cGMP, prolonging the relaxation effect of NO in vascular smooth muscle.
  • Dihydropyridines: Calcium channel blockers (e.g., Amlodipine) act on the L-type channels to prevent the initial calcium influx.

Activity: Vascular Tone Challenge

Quick Mnemonics:

MLCK: Kinase Kicks off contraction (phosphorylates).

MLCP: Phosphatase Promotes Placidity (relaxation).

Calmodulin: Smooth muscle is Calm (uses Calmodulin instead of Troponin).

Next Step: